Olivier Beauchet1,2,3,4, Harmehr Sekhon1,3,5, Liam Cooper-Brown3, Cyrille P Launay1,3, Pierrette Gaudreau6,7, José A Morais1,5,8, Gilles Allali9. 1. Department of Medicine, Division of Geriatric Medicine, Sir Mortimer B. Davis Jewish General Hospital and Lady Davis Institute for Medical Research, McGill University, Montreal, Quebec, Canada. 2. Dr. Joseph Kaufmann Chair in Geriatric Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, Canada. 3. Centre of Excellence on longevity of McGill integrated University Health Network, Quebec, Canada. 4. Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore. 5. Faculty of Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada. 6. Centre Hospitalier de l'Université de Montreal Research Center, Montreal, Quebec, Canada. 7. Department of Medicine, University of Montreal, Montreal, Quebec, Canada. 8. Division of Geriatric Medicine, McGill University Health Centre, Montreal, Quebec, Canada. 9. Department of Neurology, Geneva University Hospital and University of Geneva, Switzerland.
Abstract
BACKGROUND: The co-occurrence of slow walking speed and subjective cognitive complaint (SCC) in non-demented individuals defines motoric cognitive risk syndrome (MCR), which is a pre-dementia stage. There is no information on the association between MCR and incident dementia in Québec's older population. OBJECTIVE: The study aims to examine the association of MCR and its individual components (i.e. SCC and slow walking speed) with incident dementia in community-dwelling older adults living in the province of Québec (Canada). DESIGN: Québec older people population-based observational cohort study with 3 years of follow-up. SETTING: Community dwellings. SUBJECTS: A subset of participants (n = 1,098) in 'Nutrition as a determinant of successful aging: The Québec longitudinal study' (NuAge). METHODS: At baseline, participants with MCR were identified. Incident dementia was measured at annual follow-up visits using the Modified Mini-Mental State (≤79/100) test and Instrumental Activity Daily Living scale (≤6/8) score values. RESULTS: The prevalence of MCR was 4.2% at baseline and the overall incidence of dementia was 3.6%. MCR (Hazard Ratio (HR) = 5.18, with 95% confidence interval (CI) = [2.43-11.03] and P ≤ 0.001) and SCC alone (HR = 2.54, with 95% CI = [1.33-4.85] and P = 0.005) were associated with incident dementia, but slow walking speed was not (HR = 0.81, with 95%CI = [0.25-2.63] and P = 0.736). CONCLUSIONS: MCR and SCC are associated with incident dementia in NuAge study participants.
BACKGROUND: The co-occurrence of slow walking speed and subjective cognitive complaint (SCC) in non-demented individuals defines motoric cognitive risk syndrome (MCR), which is a pre-dementia stage. There is no information on the association between MCR and incident dementia in Québec's older population. OBJECTIVE: The study aims to examine the association of MCR and its individual components (i.e. SCC and slow walking speed) with incident dementia in community-dwelling older adults living in the province of Québec (Canada). DESIGN: Québec older people population-based observational cohort study with 3 years of follow-up. SETTING: Community dwellings. SUBJECTS: A subset of participants (n = 1,098) in 'Nutrition as a determinant of successful aging: The Québec longitudinal study' (NuAge). METHODS: At baseline, participants with MCR were identified. Incident dementia was measured at annual follow-up visits using the Modified Mini-Mental State (≤79/100) test and Instrumental Activity Daily Living scale (≤6/8) score values. RESULTS: The prevalence of MCR was 4.2% at baseline and the overall incidence of dementia was 3.6%. MCR (Hazard Ratio (HR) = 5.18, with 95% confidence interval (CI) = [2.43-11.03] and P ≤ 0.001) and SCC alone (HR = 2.54, with 95% CI = [1.33-4.85] and P = 0.005) were associated with incident dementia, but slow walking speed was not (HR = 0.81, with 95%CI = [0.25-2.63] and P = 0.736). CONCLUSIONS: MCR and SCC are associated with incident dementia in NuAge study participants.
Authors: Olivier Beauchet; Cédric Annweiler; Michele L Callisaya; Anne-Marie De Cock; Jorunn L Helbostad; Reto W Kressig; Velandai Srikanth; Jean-Paul Steinmetz; Helena M Blumen; Joe Verghese; Gilles Allali Journal: J Am Med Dir Assoc Date: 2016-02-04 Impact factor: 4.669
Authors: Harmehr Sekhon; Gilles Allali; Cyrille P Launay; John Barden; Tony Szturm; Teresa Liu-Ambrose; Victoria L Chester; Chek Hooi Wong; Olivier Beauchet Journal: Maturitas Date: 2019-02-18 Impact factor: 4.342
Authors: Erik Scherder; Laura Eggermont; Dick Swaab; Marieke van Heuvelen; Yvo Kamsma; Mathieu de Greef; Ruud van Wijck; Theo Mulder Journal: Neurosci Biobehav Rev Date: 2007-02-15 Impact factor: 8.989
Authors: Paula Iso-Markku; Urho M Kujala; Keegan Knittle; Juho Polet; Eero Vuoksimaa; Katja Waller Journal: Br J Sports Med Date: 2022-03-17 Impact factor: 18.473